Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Giacobazzi

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Bioinformatics (Oxford, England)|May 22, 2024
GateMeClass: Gate Mining and Classification of cytometry dataSimone Caligola, Luca Giacobazzi, Stefania Canè, et al.
Cell Death & Disease|April 22, 2026
c-FLIP as a master regulator of immune homeostasis and disease mechanismsEliana Urbini, Annalisa Adamo, Yushu Hu, et al.
Scientific Reports|March 20, 2024
B-cell receptor signaling activity identifies patients with mantle cell lymphoma at higher risk of progressionSimona Gambino, Francesca Maria Quaglia, Marilisa Galasso, et al.
Oncoimmunology|September 18, 2023
Immune checkpoint blockade therapy mitigates systemic inflammation and affects cellular FLIP-expressing monocytic myeloid-derived suppressor cells in non-progressor non-small cell lung cancer patientsAnnalisa Adamo, Cristina Frusteri, Sara Pilotto, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Bioinformatics (Oxford, England)|May 22, 2024
GateMeClass: Gate Mining and Classification of cytometry dataSimone Caligola, Luca Giacobazzi, Stefania Canè, et al.
Cell Death & Disease|April 22, 2026
c-FLIP as a master regulator of immune homeostasis and disease mechanismsEliana Urbini, Annalisa Adamo, Yushu Hu, et al.
Scientific Reports|March 20, 2024
B-cell receptor signaling activity identifies patients with mantle cell lymphoma at higher risk of progressionSimona Gambino, Francesca Maria Quaglia, Marilisa Galasso, et al.
Oncoimmunology|September 18, 2023
Immune checkpoint blockade therapy mitigates systemic inflammation and affects cellular FLIP-expressing monocytic myeloid-derived suppressor cells in non-progressor non-small cell lung cancer patientsAnnalisa Adamo, Cristina Frusteri, Sara Pilotto, et al.
Pageof 1